These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29523878)

  • 1. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
    Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
    Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
    Kim H; Sin JI
    Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma.
    Komel T; Bosnjak M; Kranjc Brezar S; De Robertis M; Mastrodonato M; Scillitani G; Pesole G; Signori E; Sersa G; Cemazar M
    Bioelectrochemistry; 2021 Oct; 141():107843. PubMed ID: 34139572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.
    Mukhopadhyay A; Wright J; Shirley S; Canton DA; Burkart C; Connolly RJ; Campbell JS; Pierce RH
    Gene Ther; 2019 Feb; 26(1-2):1-15. PubMed ID: 30323352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
    Kamensek U; Cemazar M; Lampreht Tratar U; Ursic K; Sersa G
    Cancer Immunol Immunother; 2018 May; 67(5):785-795. PubMed ID: 29468364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
    Ugen KE; Kutzler MA; Marrero B; Westover J; Coppola D; Weiner DB; Heller R
    Cancer Gene Ther; 2006 Oct; 13(10):969-74. PubMed ID: 16763607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.
    Shah K; Connolly RJ; Chapman T; Jaroszeski MJ; Ugen KE
    Hum Vaccin Immunother; 2012 Nov; 8(11):1722-8. PubMed ID: 23151446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of interleukin-15 to B16 melanoma by electroporation leads to tumor regression and long-term survival.
    Marrero B; Shirley S; Heller R
    Technol Cancer Res Treat; 2014 Dec; 13(6):551-60. PubMed ID: 24000979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
    Li S; Xia X; Mellieon FM; Liu J; Steele S
    Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.
    Hanna E; Zhang X; Woodlis J; Breau R; Suen J; Li S
    Cancer Gene Ther; 2001 Mar; 8(3):151-7. PubMed ID: 11332985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid IL-12 electroporation in melanoma.
    Cha E; Daud A
    Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle.
    Lucas ML; Heller R
    Mol Ther; 2001 Jan; 3(1):47-53. PubMed ID: 11162310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
    Bhatia S; Longino NV; Miller NJ; Kulikauskas R; Iyer JG; Ibrani D; Blom A; Byrd DR; Parvathaneni U; Twitty CG; Campbell JS; Le MH; Gargosky S; Pierce RH; Heller R; Daud AI; Nghiem P
    Clin Cancer Res; 2020 Feb; 26(3):598-607. PubMed ID: 31582519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.